Search Results

Test Catalog

KIPM - Overview: Ki-67(MIB-1), Pulmonary, Quantitative Immunohistochemistry, Manual

Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with carcinoid or atypical carcinoid of the lung including metastases, using a manual method

PBR - Overview: Phenobarbital, Serum

Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity

TPIC - Overview: Triosephosphate Isomerase Enzyme Activity, Blood

Evaluating individuals with chronic nonspherocytic hemolytic anemia Evaluating individuals with early onset neurologic impairment Genetic counseling for families with triosephosphate isomerase deficiency

RKUR - Overview: Potassium, Random, Urine

Determining the cause for hyper- or hypokalemia using a random urine specimen

PARVN - Overview: Parvovirus B19 Antibody, Technical Interpretation

Interpretation of serologic testing for recent or past parvovirus B19 infection This test is not useful as a screening procedure for the general population

FLUC - Overview: 5-Flucytosine, Serum

Monitoring serum concentration during therapy Evaluating potential toxicity May aid in evaluating patient compliance

Site Search

Category A - Mayo Clinic Laboratories

How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......

Guidance on subtyping of influenza A test results - Insights

Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...

Category A Infectious Substances - Mayo Clinic Laboratories

Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...

Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights

In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....

Utilization Practices for Venous Thromboembolism: A Model of Cost Savings and Efficiency at Mayo Clinic...

A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...